학술논문
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
Document Type
Article
Author
Tanzawa, S.; Ochiai, R.; Makiguchi, T.; Tasaka, S.; Inaba, M.; Nakamura, J.; Inoue, K.; Kishikawa, T.; Nakashima, M.; Fujiwara, K.; Shibayama, T.; Kohyama, T.; Ishida, H.; Kuyama, S.; Miyazawa, N.; Nakamura, T.; Miyawaki, H.; Oda, N.; Ishikawa, N.; Morinaga, R.; Kusaka, K.; Miyamoto, Y.; Yokoyama, T.; Matsumoto, C.; Tsuda, T.; Ushijima, S.; Shibata, K.; Bessho, A.; Kaira, K.; Misumi, T.; Shiraishi, K.; Matsutani, N.; Seki, N.
Source
In: Therapeutic Advances in Medical Oncology . (Therapeutic Advances in Medical Oncology, 2022, 14)
Subject
Language
English
ISSN
17588359
17588340
17588340